Expression data from murine vaginal samples following adjuvant treatment

Vaccine research today is focused on using safer, highly purified or recombinant antigens with poor immunogenicity, which has created a need for potent adjuvants. Rational design of effective and safe mucosal adjuvants for human use necessitates a thorough understanding of the mode of action of successful candidate adjuvants.

47

Lindqvist M, Nookaew I, Brinkenberg I, Samuelson E, Thörn K, Nielsen J, Harandi AM